AustinCP. Opportunities and challenges in translational science. Clin Transl Sci. Published online May13, 2021. doi:10.1111/cts.13055
2.
ButlerD. Translational research: crossing the valley of death. Nature. 2008;453(7197):840-842.
3.
CharnleyJ. The lubrication of animal joints in relation to surgical reconstruction by arthroplasty. Ann Rheum Dis. 1960;19(1):10-19.
4.
GamoNJBirknowMRSullivanD, et al. Valley of death: a proposal to build a “translational bridge” for the next generation. Neurosci Res. 2017;115:1-4.
5.
GomezPFMorcuendeJA. A historical and economic perspective on Sir John Charnley, Chas F. Thackray Limited, and the early arthoplasty industry. Iowa Orthop J. 2005;25:30-37.
6.
MeslinEMBlasimmeACambon-ThomsenA. Mapping the translational science policy “valley of death.”Clin Transl Med. 2013;2(1):14.
7.
ParrishMCTanYJGrimesKVMochly-RosenD. Surviving in the valley of death: opportunities and challenges in translating academic drug discoveries. Annu Rev Pharmacol Toxicol. 2019;59:405-421.
8.
RubioDMSchoenbaumEELeeLS, et al. Defining translational research: implications for training. Acad Med. 2010;85(3):470-475.
9.
SeyhanAA. Lost in translation: the valley of death across preclinical and clinical divide—identification of problems and overcoming obstacles. Transl Med Comm. 2019;4:18.
10.
TierneyWMMeslinEMKroenkeK. Industry support of medical research: important opportunity or treacherous pitfall?J Gen Intern Med. 2016;31(2):228-233.
